ストックスクリーナーアプリを入手
7.015
0.17%
-0.045
前日終値:
$7.06
開ける：
$7.02
24時間の取引高:
510.28K
Relative Volume:
0.09
時価総額：
$1.83B
収益：
$6.28B
当期純損益:
$700.00M
株価収益率:
2.6057
EPS:
2.6922
ネットキャッシュフロー:
$537.00M
1週間 パフォーマンス:
-14.15%
1か月 パフォーマンス:
-16.39%
6か月 パフォーマンス:
-24.70%
1年 パフォーマンス:
-56.81%
1日の値動き範囲:
$7.005
$7.24
1週間の範囲:
$6.50
$8.215
52週間の値動き範囲:
$6.18
$16.50
Organon Co Stock (OGN) Company Profile
Compare OGN vs LLY, JNJ, ABBV, AZN, NVS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
7.05 | 1.84B | 6.28B | 700.00M | 537.00M | 2.6922 |
|
LLY
Lilly Eli Co
|
1,058.89 | 929.27B | 65.18B | 20.64B | 6.44B | 22.96 |
|
JNJ
Johnson Johnson
|
243.53 | 589.19B | 94.19B | 26.80B | 20.46B | 11.05 |
|
ABBV
Abbvie Inc
|
230.95 | 402.08B | 61.16B | 4.20B | 19.68B | 2.3671 |
|
AZN
Astrazeneca Plc
|
206.29 | 317.06B | 58.80B | 10.24B | 8.98B | 3.2788 |
|
NVS
Novartis Ag Adr
|
162.42 | 307.56B | 54.72B | 14.02B | 15.32B | 7.1855 |
Organon Co Stock (OGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-09 | 開始されました | Barclays | Underweight |
| 2025-10-27 | ダウングレード | Piper Sandler | Overweight → Underweight |
| 2025-05-02 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2024-09-06 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2023-11-03 | ダウングレード | Goldman | Buy → Neutral |
| 2023-09-21 | 開始されました | Barclays | Overweight |
| 2023-03-16 | 開始されました | Raymond James | Outperform |
| 2022-10-14 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-09-06 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-08-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-04-27 | 開始されました | Goldman | Buy |
| 2022-04-06 | 再開されました | Morgan Stanley | Equal-Weight |
| 2021-10-07 | 開始されました | Piper Sandler | Neutral |
| 2021-09-01 | 開始されました | BofA Securities | Buy |
| 2021-07-22 | 開始されました | Citigroup | Buy |
| 2021-06-15 | 開始されました | JP Morgan | Neutral |
| 2021-06-11 | 開始されました | Morgan Stanley | Equal-Weight |
| 2021-06-10 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Organon Co (OGN) 最新ニュース
Organon & Co. (NYSE:OGN) Q4 2025 Earnings Call Transcript - Insider Monkey
Assessing Organon (OGN) Valuation After Earnings Miss And Flat 2026 Revenue Guidance - Yahoo Finance
LSV Asset Management Has $83.67 Million Holdings in Organon & Co. $OGN - MarketBeat
Organon Reshapes Women’s Health Focus With Nexplanon Shift And Jada Sale - Yahoo Finance
Organon & Co. Q4 Earnings Call Highlights - MarketBeat
Organon (NYSE:OGN) Reports Q4 CY2025 In Line With Expectations - The Globe and Mail
Organon & Co To Go Ex-Dividend On February 23rd, 2026 With 0.02 USD Dividend Per Share - 富途牛牛
Organon Earnings Call Balances Stability With Rising Risks - TipRanks
Organon Q3 Net Margin Squeeze Challenges Bullish Earnings Growth Narratives - simplywall.st
Organon Co earnings missed by $0.13, revenue fell short of estimates - Investing.com UK
Organon Shares Slide on Quarterly Loss and Cautious Outlook - AD HOC NEWS
Organon (OGN) Q4 2025 Earnings Call Transcript - The Globe and Mail
Organon & Co. (NYSE:OGN) Announces Quarterly Earnings Results, Misses Estimates By $0.11 EPS - MarketBeat
Organon: Overview of Fourth Quarter Financial Results - Bitget
Bronstein, Gewirtz & Grossman, LLC Encourages Organon & Co. (OGN) Investors to Inquire about Securities Investigation - ACCESS Newswire
Organon Q4 Earnings ReviewPoor Results Trigger Predictable Sell-Off (NYSE:OGN) - Seeking Alpha
Organon sees FY26 revenue $6.2B, consensus $6.11B - TipRanks
Organon outlines flat $6.2B revenue and $1.9B EBITDA targets for 2026 as cost controls and portfolio shifts take center stage - MSN
Organon reports Q4 adjusted EPS 63c, consensus 73c - TipRanks
Organon Shares Fall After 4Q Earnings Miss Expectations - 富途牛牛
Organon & Co. (NYSE:OGN) Shares Gap Down Following Weak Earnings - MarketBeat
Organon (OGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
OGN: 2025 results show stable revenue and EBITDA, with 2026 guidance flat amid margin and policy headwinds - TradingView
Organon Q4 2025 slides: Revenue declines accelerate, stock tumbles on earnings miss By Investing.com - Investing.com India
Organon Q4 2025 slides: Revenue declines accelerate, stock tumbles on earnings miss - Investing.com
Organon Co earnings missed by $0.13, revenue fell short of estimates By Investing.com - Investing.com Canada
Earnings call transcript: Organon Q4 2025 reveals EPS miss, stock drops 10.8% - Investing.com
Organon (OGN) Misses Q4 Earnings and Revenue Estimates - Yahoo Finance
Organon falls as women’s health unit drives Q4 miss (OGN:NYSE) - Seeking Alpha
Organon: Q4 Earnings Snapshot - kare11.com
Organon Q4 Adjusted Earnings, Revenue Fall; 2026 Revenue Outlook Issued - 富途牛牛
Earnings snapshot: Organon & Co. misses bottom-line estimates; initiates FY26 outlook - MSN
Organon & Co (NYSE:OGN) Shares Drop on Q4 Earnings Miss and Flat 2026 Outlook - ChartMill
(OGN) Organon Expects 2026 Revenue About $6.22B, vs. FactSet Est of $6.11B - marketscreener.com
Earnings Flash (OGN) Organon Posts Q4 Revenue $1.51B, vs. FactSet Est of $1.54B - marketscreener.com
Organon shares fall over 5% as Q4 earnings miss expectations By Investing.com - Investing.com South Africa
Press Release: Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025 - 富途牛牛
Organon earnings: What to look for from OGN - MSN
Organon Q4 Earnings Preview: Cautious view amid weak year (OGN:NYSE) - Seeking Alpha
Earnings Preview: Organon - Benzinga
Organon & Co. (OGN) Stock Analysis: Exploring A Potential 18.3% Upside In Healthcare - DirectorsTalk Interviews
Organon Earnings: What To Look For From OGN - The Globe and Mail
Organon Q4 Earnings Preview: Revenue Decline Projected Amid Sector VolatilityNews and Statistics - IndexBox
Aug Gainers: Does Organon Co meet Warren Buffetts criteria2025 Momentum Check & Free High Return Stock Watch Alerts - baoquankhu1.vn
Organon & Co. (NYSE:OGN) Stock Price Down 5.2%Here's What Happened - MarketBeat
Down 72% In 3 Years, Can Organon Stock Finally Recover In 2026? - TIKR.com
Organon & Co (OGN.US) will release its earnings report before the market opens on February 12. - 富途牛牛
Contraceptive Pills Market Is Going to Boom | Pfizer Inc • Bayer AG • Organon & Co - openPR.com
FDA expands use of Organon’s contraception implant up to 5 years - MSN
Organon & Co. (NYSE:OGN) Receives Consensus Rating of "Reduce" from Brokerages - MarketBeat
Organon Launches Third Edition of Women's Health Accelerator Program Across Middle East, Turkey & Africa - The Malaysian Reserve
Organon Co (OGN) 財務データ
収益
当期純利益
現金流量
EPS
1.38%
大文字化:
|
ボリューム (24 時間):